🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 70387R106
- Market Cap
- Small Cap
Business: PAVmed, Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. Its subsidiary, Lucid Diagnostics Inc. (NASDAQ: LUCD), is a commercial-stage cancer prevention medical diagnostics company. The Company’s goal is to enhance and accelerate value creation by employing a business model focused on capital efficiency and speed to market. PAVmed is further expanding its pipeline through engagements with clinician innovators and leading academic medical centers.
Notes: July 26, 2016 -- PAVmed, Inc. announced today that the common stock and warrants underlying the units sold in its initial public offering would commence separate trading on July 27, 2016. The common stock and warrants will be listed on the Nasdaq Capital Market under the symbols PAVM and PAVMW, respectively. The units, which are currently trading on Nasdaq under the symbol PAVMU, will no longer be listed or trade following the separation. PAVmed completed its initial public offering of 1,060,000 units at an offering price of $5.00 per unit on April 28, 2016. Each unit consisted of one share of common stock and one warrant. Each warrant entitles the holder to purchase one share of common stock at a price of $5.00 per share. The warrants will become exercisable commencing on October 28, 2016.
Company Contact
- CEO
- Dr. Lishan Aklog
- CFO
- Dennis McGrath
- Headquarters
- 360 Madison Avenue, 25th Floor, New York, NY 10017
- Phone
- 917-813-1828
- Investor Relations
- Matt Riley · 201-803-0388 · mjr@pavmed.com